Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC +1.13%85 EV-to-EBIT is 29.03 as of Jul. 19, 2026, which is 4% above its 10-year median of 27.88. GuruFocus rates ASX:RHC with a GF Score™ of 85/100 and a GF Value™ of A$50.81 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 74.57% on this metric.
The historical rank and industry rank for Ramsay Health Care's EV-to-EBIT or its related term are showing as below:
ASX:RHC'
s EV-to-EBIT Range Over the Past 10 Years
Min: 15.4 Med: 27.88 Max: 50.88
Current: 29.03
During the past 13 years, the highest EV-to-EBIT of Ramsay Health Care was 50.88. The lowest was 15.40. And the median was 27.88.
ASX:RHC's EV-to-EBIT is ranked worse than 74.57% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.86
vs ASX:RHC: 29.03
Ramsay Health Care (ASX:RHC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ramsay Health Care's Enterprise Value for the quarter that ended in Dec. 2025 was A$20,003 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ramsay Health Care's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$759 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care EV-to-EBIT Related Terms
Ramsay Health Care EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Ramsay Health Care's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ramsay Health Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's EV-to-EBIT falls into.
Ramsay Health Care's current Enterprise Value is A$22,025 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ramsay Health Care's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$759 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care (ASX:RHC) has a EV-to-EBIT of 29.03 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ramsay Health Care and its competitors. This is near median its historical median of 27.88. Over the past decade, Ramsay Health Care's EV-to-EBIT has ranged from 15.40 to 50.88. According to the industry distribution chart, Ramsay Health Care ranks #349 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 74.6%.
Is Ramsay Health Care's EV-to-EBIT too high?
Ramsay Health Care's current EV-to-EBIT of 29.03 is near median its 10-year median of 27.88. Over the past 10 years, this metric has ranged from a low of 15.40 to a high of 50.88. The Healthcare Providers & Services industry median EV-to-EBIT is 15.86. Ramsay Health Care's value of 29.03 is 83% above this industry median. Based on the distribution chart, Ramsay Health Care ranks #349 out of 468 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramsay Health Care has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #349 out of 468 companies for EV-to-EBIT. This places Ramsay Health Care in the lower half of its industry. The industry median EV-to-EBIT is 15.86. Ramsay Health Care's value of 29.03 is 83% above this benchmark. Historically, Ramsay Health Care's own EV-to-EBIT has ranged from 15.40 to 50.88 over the past decade. While the company's 10-year median is 27.88 vs. the industry median of 15.86, Ramsay Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.86, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Health Care's current EV-to-EBIT of 29.03 is 83% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ramsay Health Care and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current EV-to-EBIT is 29.03, which is near median its own 10-year median of 27.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.81, compared to a current price of A$43.12 — trading 15.1% below its estimated fair value. The current EV-to-EBIT is 29.03, which is near median its 10-year median of 27.88 and 83% above the Healthcare Providers & Services industry median of 15.86. Ramsay Health Care's overall GF Score™ is 85/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current EV-to-EBIT is 29.03 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued.
The current stock price of A$43.12 is trading 15.1% below its estimated GF Value™ of A$50.81.
GuruFocus considers Ramsay Health Care to be Modestly Undervalued.
Key valuation signals for ASX:RHC:
EV-to-EBIT: 29.03 (near median its 10-year median of 27.88)
GF Value™: A$50.81 vs. price of A$43.12 (15.1% below fair value)
Industry Position: 83% above the Healthcare Providers & Services median (#349 of 468)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
85GF Score
Get the complete analysis for ASX:RHC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
